|
|||||
![]() |
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter![]() |
Ticker | Owner | Relationship | Date | Transaction | Cost ![]() |
#Shares | Value ($) | #Shares Total | SEC Form 4 |
GNLX | Yu Yong | VP, Clinical Trial Operations | Sep 20 | Option Exercise | 6.00 | 6,000 | 36,000 | 112,135 | Sep 21 04:35 PM |
GNLX | Yu Yong | VP, Clinical Trial Operations | Sep 20 | Sale | 27.96 | 6,000 | 167,786 | 106,135 | Sep 21 04:35 PM |
GNLX | Yu Yong | VP, Clinical Trial Operations | Sep 15 | Option Exercise | 6.00 | 10,400 | 62,400 | 116,535 | Sep 18 08:13 PM |
GNLX | Yu Yong | VP, Clinical Trial Operations | Sep 15 | Sale | 21.89 | 10,400 | 227,630 | 106,135 | Sep 18 08:13 PM |
GNLX | Yu Yong | VP, Clinical Trial Operations | Sep 13 | Sale | 21.14 | 29,800 | 629,927 | 106,135 | Sep 15 08:06 PM |
GNLX | Yu Yong | VP, Clinical Trial Operations | Aug 30 | Sale | 24.70 | 19,800 | 489,060 | 135,935 | Aug 30 07:22 PM |
GNLX | Yu Yong | VP, Clinical Trial Operations | Aug 18 | Sale | 23.73 | 3,265 | 77,478 | 155,735 | Aug 22 04:14 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite